Connect with us

Health

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients – The Lancet

In December, 2020, the Israeli Government approved the BNT162b2 COVID-19 vaccine andinitiated a national immunisation campaign prioritising health-care workers…

Published

on

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy   Terms and Conditions

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending